Advertisement

The Scientist

» patent

Most Recent

image: Who Owns CRISPR?

Who Owns CRISPR?

By | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

6 Comments

American universities top a list of educational institutions ranked according to their number of international patent applications.

0 Comments

image: Myriad Settles Suit

Myriad Settles Suit

By | January 26, 2015

The Utah-based firm has settled its lawsuit claiming patent infringement against Pathway Genomics.

0 Comments

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

image: Keeping Up with IP

Keeping Up with IP

By | September 1, 2014

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

0 Comments

image: Patent Plea Ping Pong

Patent Plea Ping Pong

By | August 21, 2014

A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.

1 Comment

image: Yet Another Lawsuit over Genetic Tests

Yet Another Lawsuit over Genetic Tests

By | June 17, 2014

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

0 Comments

image: Competition for CRISPR Commercialization

Competition for CRISPR Commercialization

By | May 1, 2014

Researchers stake their proprietary claim on the genome-editing technique.

0 Comments

image: Patent Covers CRISPR

Patent Covers CRISPR

By | April 17, 2014

The Broad Institute has succeeded in getting the first patent for the hot new genome-editing technique.

3 Comments

image: Another Legal Setback for Myriad

Another Legal Setback for Myriad

By | March 11, 2014

A judge declines Myriad Genetics’s request to block its competitors from selling BRCA tests.  

0 Comments

Popular Now

  1. How Fats Influence the Microbiome
  2. Opinion: Making Progress by Slowing Down
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Mitochondria Exchange
    News Analysis Mitochondria Exchange

    A decade of research on intercellular mitochondrial transfer has answered some long-standing questions and raised new ones.

Advertisement
Advertisement